DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Chervinsky P. et al.
Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis.
Ann Allergy Asthma Immunol 2003;
91: 160-167
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.